{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:40:01Z","timestamp":1755848401118,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To evaluate the outcomes of localized crosslinking (L-CXL) for progressive keratoconus utilizing a standard CXL device.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>This retrospective cohort study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>included patients diagnosed with progressive keratoconus and treated with a localized cone-centered CXL (based on corneal topography) using the accelerated CXL protocol with a standard CXL device.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We Identified 24consecutive eyes. The average BDVA before CXL was 0.282\u2009\u00b1\u20090.35 LogMar, remained overall stable at 12-month post-surgery at 0.204\u2009\u00b1\u20090.173 LogMar (<jats:italic>P<\/jats:italic>\u2009=\u20090.395). Ten eyes (of eight patients) (42%) demonstrated an improvement in BDVA at 12\u00a0months of 1\u20134 lines and none of the other eyes lost BDVA. These eyes had significantly lower pre-operative BDVA than the stable eyes (<jats:italic>P<\/jats:italic>\u2009=\u20090.034). Ten eyes (of eight patients) (42%) demonstrated an improvement in K-max at 12\u00a0months post-operatively, of at least 1D; six of these eyes had improvement in both BDVA and Kmax. None of the eyes developed an increase in Kmax throughout the follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this series, cone-centered L-CXL, using a conventional CXL device resulted in significant stabilization and even improvements in BDVA and Kmax in almost half of the eyes, without significant adverse events. Addressing the CXL application onto the affected area results in beneficial results.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00417-025-06803-y","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:14:31Z","timestamp":1743326071000},"page":"1949-1956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of localized corneal collagen crosslinking with a conventional device in progressive keratoconus"],"prefix":"10.1007","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-8862","authenticated-orcid":false,"given":"Ofri","family":"Vorobichik Berar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Shemesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Gomel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoav","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina S.","family":"Barequet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"6803_CR1","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s10792-017-0699-8","volume":"38","author":"S Mukhtar","year":"2018","unstructured":"Mukhtar S, Ambati BK (2018) Pediatric keratoconus: a review of the literature. Int Ophthalmol 38:2257\u20132266. https:\/\/doi.org\/10.1007\/s10792-017-0699-8","journal-title":"Int Ophthalmol"},{"key":"6803_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0002-9394(86)90817-2","volume":"101","author":"RH Kennedy","year":"1986","unstructured":"Kennedy RH, Bourne WM, Dyer JA (1986) A 48-year clinical and epidemiologic study of keratoconus. Am J Ophthalmol 101:267\u2013273. https:\/\/doi.org\/10.1016\/0002-9394(86)90817-2","journal-title":"Am J Ophthalmol"},{"key":"6803_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/s0002-9394(02)02220-1","volume":"135","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T (2003) Riboflavin\/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620\u2013627. https:\/\/doi.org\/10.1016\/s0002-9394(02)02220-1","journal-title":"Am J Ophthalmol"},{"key":"6803_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5301\/ejo.5000916","volume":"27","author":"DPS O\u2019Brart","year":"2017","unstructured":"O\u2019Brart DPS (2017) Corneal collagen crosslinking for corneal ectasias: a review. Eur J Ophthalmol 27:253\u2013269. https:\/\/doi.org\/10.5301\/ejo.5000916","journal-title":"Eur J Ophthalmol"},{"key":"6803_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/bjophthalmol-2017-311017","volume":"102","author":"YM Wang","year":"2018","unstructured":"Wang YM, Chan TC, Yu MCY, Jhanji V (2018) Comparative evaluation of progression rate in keratoconus before and after collagen crosslinking. Br J Ophthalmol 102:1109\u20131113. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311017","journal-title":"Br J Ophthalmol"},{"key":"6803_CR6","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.1167\/iovs.11-7395","volume":"52","author":"A Sinha Roy","year":"2011","unstructured":"Sinha Roy A, Dupps WJJ (2011) Patient-specific computational modeling of keratoconus progression and differential responses to collagen cross-linking. Invest Ophthalmol Vis Sci 52:9174\u20139187. https:\/\/doi.org\/10.1167\/iovs.11-7395","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6803_CR7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3928\/1081597X-20170201-02","volume":"33","author":"M Cassagne","year":"2017","unstructured":"Cassagne M, Piern\u00e9 K, Galiacy SD et al (2017) Customized topography-guided corneal collagen cross-linking for keratoconus. J Refract Surg 33:290\u2013297. https:\/\/doi.org\/10.3928\/1081597X-20170201-02","journal-title":"J Refract Surg"},{"key":"6803_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.4103\/ijo.IJO_648_17","volume":"65","author":"GS Sachdev","year":"2017","unstructured":"Sachdev GS, Sachdev M (2017) Recent advances in corneal collagen cross-linking. Indian J Ophthalmol 65:787\u2013796. https:\/\/doi.org\/10.4103\/ijo.IJO_648_17","journal-title":"Indian J Ophthalmol"},{"key":"6803_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3928\/1081597X-20190304-01","volume":"35","author":"JN Webb","year":"2019","unstructured":"Webb JN, Langille E, Hafezi F et al (2019) Biomechanical impact of localized corneal cross-linking beyond the irradiated treatment area. J Refract Surg 35:253\u2013260. https:\/\/doi.org\/10.3928\/1081597X-20190304-01","journal-title":"J Refract Surg"},{"key":"6803_CR10","unstructured":"Usher D, Mukherjee A, Smirnov M, Hill J, Eddington W, Liu C, et al (2019) Impact of eye motion and active vs. passive eye tracking on refractive crosslinking (abstract).\u00a0Investig\u00a0Ophthalmol Vis Sci 60:327"},{"key":"6803_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.4103\/jovr.jovr_30_16","volume":"12","author":"S Zarei-Ghanavati","year":"2017","unstructured":"Zarei-Ghanavati S, Khakshour H, Vejdani M et al (2017) Evaluation of changes in visual acuity, contrast sensitivity and aberrations in patients with keratoconus after corneal collagen cross-linking. J Ophthalmic Vis Res 12:260\u2013264. https:\/\/doi.org\/10.4103\/jovr.jovr_30_16","journal-title":"J Ophthalmic Vis Res"},{"key":"6803_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajo.2023.01.022","volume":"250","author":"F Raiskup","year":"2023","unstructured":"Raiskup F, Herber R, Lenk J et al (2023) Corneal crosslinking with riboflavin and UVA light in progressive keratoconus: fifteen-year results. Am J Ophthalmol 250:95\u2013102. https:\/\/doi.org\/10.1016\/j.ajo.2023.01.022","journal-title":"Am J Ophthalmol"},{"key":"6803_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/OPTH.S137712","volume":"11","author":"WK Lim","year":"2017","unstructured":"Lim WK, Da SZ, Choi HKY, Theng JTS (2017) Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia. Clin Ophthalmol 11:1205\u20131211. https:\/\/doi.org\/10.2147\/OPTH.S137712","journal-title":"Clin Ophthalmol"},{"key":"6803_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1167\/iovs.06-1177","volume":"48","author":"N Morishige","year":"2007","unstructured":"Morishige N, Wahlert AJ, Kenney MC et al (2007) Second-harmonic imaging microscopy of normal human and keratoconus cornea. Invest Ophthalmol Vis Sci 48:1087\u20131094. https:\/\/doi.org\/10.1167\/iovs.06-1177","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6803_CR15","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1167\/iovs.04-1253","volume":"46","author":"KM Meek","year":"2005","unstructured":"Meek KM, Tuft SJ, Huang Y et al (2005) Changes in collagen orientation and distribution in keratoconus corneas. Invest Ophthalmol Vis Sci 46:1948\u20131956. https:\/\/doi.org\/10.1167\/iovs.04-1253","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6803_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ajo.2016.02.029","volume":"166","author":"TG Seiler","year":"2016","unstructured":"Seiler TG, Fischinger I, Koller T et al (2016) Customized corneal cross-linking: one-year results. Am J Ophthalmol 166:14\u201321. https:\/\/doi.org\/10.1016\/j.ajo.2016.02.029","journal-title":"Am J Ophthalmol"},{"key":"6803_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3928\/1081597X-20170621-07","volume":"33","author":"R Shetty","year":"2017","unstructured":"Shetty R, Pahuja N, Roshan T et al (2017) Customized corneal cross-linking using different UVA beam profiles. J Refract Surg 33:676\u2013682. https:\/\/doi.org\/10.3928\/1081597X-20170621-07","journal-title":"J Refract Surg"},{"key":"6803_CR18","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1097\/ICO.0000000000001707","volume":"37","author":"MW Belin","year":"2018","unstructured":"Belin MW, Lim L, Rajpal RK et al (2018) Corneal cross-linking: current USA status: report from the cornea society. Cornea 37:1218\u20131225. https:\/\/doi.org\/10.1097\/ICO.0000000000001707","journal-title":"Cornea"},{"key":"6803_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jcrs.2011.11.029","volume":"38","author":"NO Brooks","year":"2012","unstructured":"Brooks NO, Greenstein S, Fry K, Hersh PS (2012) Patient subjective visual function after corneal collagen crosslinking for keratoconus and corneal ectasia. J Cataract Refract Surg 38:615\u2013619. https:\/\/doi.org\/10.1016\/j.jcrs.2011.11.029","journal-title":"J Cataract Refract Surg"},{"key":"6803_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/j.jcrs.0000000000000347","volume":"46","author":"C Mazzotta","year":"2020","unstructured":"Mazzotta C, Sgheri A, Bagaglia SA et al (2020) Customized corneal crosslinking for treatment of progressive keratoconus: clinical and OCT outcomes using a transepithelial approach with supplemental oxygen. J Cataract Refract Surg 46:1582\u20131587. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000347","journal-title":"J Cataract Refract Surg"},{"key":"6803_CR21","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/bjophthalmol-2016-309210","volume":"101","author":"M Nordstr\u00f6m","year":"2017","unstructured":"Nordstr\u00f6m M, Schiller M, Fredriksson A, Behndig A (2017) Refractive improvements and safety with topography-guided corneal crosslinking for keratoconus: 1-year results. Br J Ophthalmol 101:920\u2013925. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309210","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06803-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06803-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T07:16:10Z","timestamp":1755846970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06803-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6803"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06803-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the sheba medical center IRB, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}